| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/07/2009 | US20090117137 Peptide epitopes of apolipoprotein b |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117130 Kallikrein-inhibitor therapies |
| 05/07/2009 | US20090117123 Immunopeptides of hpv e6 and e7 proteins |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117117 Targeting abcb5 for cancer therapy |
| 05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
| 05/07/2009 | US20090117102 Methods and compositions using CD3 agonists |
| 05/07/2009 | US20090117099 Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| 05/07/2009 | US20090117095 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 05/07/2009 | US20090117093 Granulysin peptides and methods of use thereof |
| 05/07/2009 | US20090117092 Collagenolytic active enzyme containing compositions, and their use in the dental field |
| 05/07/2009 | US20090117091 Methods for treating pompe disease |
| 05/07/2009 | US20090117090 Inhibition of glycogen synthase kinase 3 beta in arterial repair and stent re-endothelialization |
| 05/07/2009 | US20090117085 Mntf differentiation and growth of stem cells |
| 05/07/2009 | US20090117084 Bacteriophage and prophage proteins in cancer gene therapy |
| 05/07/2009 | US20090117078 Crosslinked compounds and methods of making and using thereof |
| 05/07/2009 | US20090117077 Polyethylene glycol-interferon alpha conjugate |
| 05/07/2009 | US20090117076 Methods For Treating Tumor Cells |
| 05/07/2009 | US20090117075 Temperature Responsive Delivery Systems |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090117073 Use of a fusion protein targeting the ed-b fibronectin domain for treatment of atherosclerosis |
| 05/07/2009 | US20090117070 Methods and Crosslinked Polymer Compositions for Cartilage Repair |
| 05/07/2009 | US20090117038 Breast Endothelial Cell Expression Patterns |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | DE102007052114A1 Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle A method of modulating the function of the growth or differentiation of a cell |
| 05/07/2009 | DE102007051914A1 Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel A process for preparing loaded with growth factors, as well as particles, the particles thus obtained |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |
| 05/07/2009 | CA2740310A1 Altered cadherin processing in tumor cells |
| 05/07/2009 | CA2739011A1 Osteoarthritis gene therapy |
| 05/07/2009 | CA2707861A1 Glucagon antagonists |
| 05/07/2009 | CA2704774A1 Keratin derivatives and methods of making same |
| 05/07/2009 | CA2704627A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | CA2704562A1 Polypeptide compound |
| 05/07/2009 | CA2704422A1 Compositions and methods of enhancing immune responses to eimeria |
| 05/07/2009 | CA2704397A1 Hla-dr binding peptides and their uses |
| 05/07/2009 | CA2704383A1 Rationally-designed single-chain meganucleases with non-palindromic recognition sequences |
| 05/07/2009 | CA2704262A1 Ingestible film composition |
| 05/07/2009 | CA2704246A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | CA2704221A1 Bone-reinforcing food material |
| 05/07/2009 | CA2704190A1 Nell-1 compositions |
| 05/07/2009 | CA2704144A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 05/07/2009 | CA2704092A1 Food material for inhibiting osteoclastogenesis |
| 05/07/2009 | CA2704054A1 Vancomycin and teicoplanin anhydrous formulations for topical use |
| 05/07/2009 | CA2704042A1 Bone resorption inhibitory food material for inhibiting bone resorption |
| 05/07/2009 | CA2703948A1 Recombinant factor viii having increased stability |
| 05/07/2009 | CA2703943A1 Albumin fusion proteins |
| 05/07/2009 | CA2703770A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 05/07/2009 | CA2703393A1 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 05/07/2009 | CA2703170A1 Composition |
| 05/07/2009 | CA2702289A1 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 05/07/2009 | CA2700662A1 Lh liquid formulations |
| 05/06/2009 | EP2056111A1 Methods and compositions for regulating protein-protein interactions |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055715A1 Anticomplement polypeptides of ixodes ricinus |
| 05/06/2009 | EP2055714A2 Biological photo-receptors as directly light-controlled ion channels and their use |
| 05/06/2009 | EP2055712A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 05/06/2009 | EP2055313A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055310A1 Further use of protein kinase N beta |
| 05/06/2009 | EP2055309A1 Vancomycin and Teicoplanin anhydrous formulations for topical use |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055302A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/06/2009 | EP2054440A2 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin 5 1, having proangiogenic activity |
| 05/06/2009 | EP2054439A1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 05/06/2009 | EP2054438A1 Truncated pth peptides with a cyclic conformation |
| 05/06/2009 | EP2054437A2 Albumin-insulin fusion proteins |
| 05/06/2009 | EP2054434A1 Myostatin antagonists |
| 05/06/2009 | EP2054433A1 Diuretic and natriuretic polypeptides |
| 05/06/2009 | EP2054430A2 Promiscuous her-2/neu cd4 t cell epitopes |
| 05/06/2009 | EP2054121A1 Methods for modulating apoptosis in platelets |
| 05/06/2009 | EP2054082A2 Therapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 05/06/2009 | EP2054078A2 Long-lasting absorption of flavonoids |
| 05/06/2009 | EP2054077A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 05/06/2009 | EP2054076A2 Combination therapy for treatment of viral infections |
| 05/06/2009 | EP2054075A1 Treatment of graft-versus-host disease |
| 05/06/2009 | EP2054074A1 Modified erythropoietin |
| 05/06/2009 | EP2054073A1 Pharmaceutical compositions for sustained release delivery of peptides |
| 05/06/2009 | EP2054050A2 Treatment of cartilage disorders with fgf-18 |
| 05/06/2009 | EP2054032A2 Flowable carrier matrix |
| 05/06/2009 | EP2053915A2 Methods for attenuating release of inflammatory mediators and peptides useful therein |
| 05/06/2009 | EP1877436A4 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 05/06/2009 | EP1807065A4 Methods and compositions for treating nephrogenic diabetes insipidus |
| 05/06/2009 | EP1781686B1 Vla-4 antagonists |
| 05/06/2009 | EP1745069B1 Therapeutic use of growth factor nsg33 |
| 05/06/2009 | EP1521593B1 Transdermal botulinum toxin compositions |
| 05/06/2009 | EP1474439B1 Dipeptides and tripeptides with anti-inflammatory activity |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1363933B1 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
| 05/06/2009 | EP1309336B1 Derivatives of laspartomycin and preparation and use thereof |
| 05/06/2009 | EP1240900B1 Factor viii or von willebrand factor for the treatment of hemorrhagic diseases associating thrombopathy |
| 05/06/2009 | EP1224271B1 Expression of recombinant mature lysostaphin |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1173155A4 Gum pad for delivery of medication to mucosal tissues |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP0742824B1 Wd-40-derived peptides and uses thereof |
| 05/06/2009 | EP0697881B2 New cyclosporine-containing pharmaceutical compositions for oral administration |